Crossmark

Silymarin as a preventive or therapeutic measure for chemotherapy and radiotherapy-induced adverse reactions: a comprehensive review of preclinical and clinical data

Crossref DOI link: https://doi.org/10.1007/s00228-022-03434-8

Published Online: 2022-12-01

Published Print: 2023-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ghodousi, Mahsa

Karbasforooshan, Hedyieh

Arabi, Leila https://orcid.org/0000-0003-1623-3346
Elyasi, Sepideh https://orcid.org/0000-0001-9857-1175
License Information

Text and Data Mining valid from 2022-12-01

Version of Record valid from 2022-12-01
More Information

Article History

Received: 30 August 2022

Accepted: 21 November 2022

First Online: 1 December 2022

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below